Product Recalls in Louisiana

Product recalls affecting Louisiana — including food, drugs, consumer products, medical devices, and vehicles distributed to Louisiana. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,678 recalls have been distributed to Louisiana in the last 12 months.

51,202 total recalls
2,678 in last 12 months

Showing 92019220 of 13,548 recalls

DrugMarch 17, 2016· Impax Laboratories, Inc.

Recalled Item: Fenofibrate Capsules (Micronized) 200 mg Recalled by Impax Laboratories,...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp. Date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 17, 2016· Impax Laboratories, Inc.

Recalled Item: Fenofibrate Capsules (Micronized) 134 mg Recalled by Impax Laboratories,...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp. Date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 16, 2016· Actavis Pharma Inc

Recalled Item: Ciprofloxacin Ophthalmic Solution (0.3% as base) Recalled by Actavis Pharma...

The Issue: Failed Impurities/Degradation Specifications: Firm voluntarily recalled...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 15, 2016· Hospira Inc.

Recalled Item: Quelicin (Succinylcholine Chloride) Injection Recalled by Hospira Inc. Due...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 14, 2016· Impax Laboratories, Inc.

Recalled Item: Dextroamphetamine Sulfate Tablets USP Recalled by Impax Laboratories, Inc....

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 3 (Papaverine 20 mg Recalled by Meditech Laboratories, Inc Due to...

The Issue: Stability Does Not Support Expiry: manufactured with an active ingredient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 2 (Papaverine 9 mg Recalled by Meditech Laboratories, Inc Due to...

The Issue: Superpotent Drug: one ingredient was found to be above assay specification.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 1 (Papaverine 1.8 mg Recalled by Meditech Laboratories, Inc Due to...

The Issue: Stability Does Not Support Expiry: manufactured with an active ingredient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 4 (Papaverine 18 mg Recalled by Meditech Laboratories, Inc Due to...

The Issue: Lack of Assurance of Sterility: incomplete or missing data regarding production.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 0 (PGE 20 mcg/mL) Injection Recalled by Meditech Laboratories, Inc...

The Issue: Lack of Assurance of Sterility: incomplete or missing data regarding production.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 2 (Papaverine 9 mg Recalled by Meditech Laboratories, Inc Due to...

The Issue: Stability Does Not Support Expiry: manufactured with an active ingredient...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Impax Laboratories, Inc.

Recalled Item: Dextroamphetamine Sulfate Tablets USP Recalled by Impax Laboratories, Inc....

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 14, 2016· Meditech Laboratories, Inc

Recalled Item: Formula 9 (Papaverine 0.9 mg Recalled by Meditech Laboratories, Inc Due to...

The Issue: Lack of Assurance of Sterility: incomplete or missing data regarding production.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: CGMP Deviations: finished products manufactured using active pharmaceutical...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 11, 2016· Jubilant Draximage Inc

Recalled Item: SODIUM IODIDE I 131 CAPSULE Recalled by Jubilant Draximage Inc Due to...

The Issue: Labeling: Label Error on Declared Strength

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: CGMP Deviations: finished products manufactured using active pharmaceutical...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone Sodium (Sterile) USP active pharmaceutical ingredient Recalled...

The Issue: CGMP Deviations: active pharmaceutical ingredient intermediates failed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: CGMP Deviations: finished products manufactured using active pharmaceutical...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 11, 2016· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: CGMP Deviations: finished products manufactured using active pharmaceutical...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 9, 2016· Teva Pharmaceuticals USA

Recalled Item: Amikacin Sulfate injection USP Recalled by Teva Pharmaceuticals USA Due to...

The Issue: Presence of Particulate Matter: particulate matter identified as glass in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund